Roxithromycin Tablets for Infection of Ear, Nose and Throat

• Sample: Free
• Transport Package: Box
• Specification: 150mg*6tab/box
• Trademark: FUL
• Origin: China
• Model NO.: FC060-1
• Production Capacity: 10000PCS/

Product Description

Item Name:Roxithromycin Tablets
Molecular formula:C₄₁H₇₆N₂O₁₅

Item Description

Item nanme:Roxithromycin Tablets
Item character:The product is white

Indication:
It is used to treat infections caused by roxithromycin sensitive pathogens.
Ear, nose, throat infection: tonsillitis, pharyngitis, sinusitis
Respiratory tract infection: acute bronchitis, pneumonia
Skin and soft tissue infections: pustulosis
Genitourinary tract infection: non gonococcal urethritis

Item specifications:150mg*6tab/box

Usage and dosage:The product should be taken 15 minutes before meals or empty stomach (such as 3 hours after meal) with sufficient liquid, and swallowed completely. The best effect is to take this product on an empty stomach.
The dose and prescription were determined by the severity of infection, the sensitivity of pathogens to drugs and the comprehensive health status of patients. The general course of treatment is 5-10 days.
Adults can take 300mg film coated tablets once a day every morning; Or 150mg one tablet, twice a day; Or 150mg two tablets, once a day. Patients with weight less than 40kg were not suitable for 300mg at a time.
Dose of medication for patients with liver function impairment - daily dose of patients with severe liver function impairment should be halved (see [precautions].
Dose of administration in patients with renal dysfunction - according to the pharmacokinetic results available, dose adjustment is not required for patients with renal dysfunction.
However, it is suggested that the concentration of roxithromycin in serum be monitored in patients with renal dysfunction. If necessary, the dosage should be reduced or the interval of administration should be prolonged.
If the liver and kidney function are seriously damaged, the serum roxithromycin concentration should be monitored regularly. If necessary, the dosage should be adjusted.
Dose of medication in elderly patients - if renal function damage is purely age-related, there is no need to reduce the dose.
The duration of the drug use depends on the clinical and bacteriological results. If signs of infection subside, treatment should continue for at least two days.
The treatment of streptococcal infection is at least 10 days to prevent recurrence and later complications. It is also suitable for the treatment of non gonococcal urethritis.
However, roxithromycin should not be taken for more than 4 weeks unless there is clinical experience available.

Adverse reactions
Allergic reaction:
Occasionally (≥ 0.1% - < 1%), the use of roxithromycin treatment can lead to allergic reactions of different severity. Most of these allergic reactions are skin and mucous membrane reactions, such as redness, redness and swelling with or without pruritus or purpura, swelling of the face, tongue and / or throat, dyspnea and even fatal shock. In these cases, roxithromycin should be stopped immediately; In some cases, appropriate treatment (such as electric shock therapy) should be given immediately.
Gastrointestinal adverse reactions: 1
Roxithromycin often (≥ 1% - < 10%) can lead to gastrointestinal disorders, such as nausea, retching and / or vomiting, stomachache and diarrhea. In rare cases (≥ 0.01% - < 0.1%), it can lead to bloody diarrhea or pseudomembranous enteritis.
Effects on liver and bile duct: 1
Occasionally (≥ 0.1% - < 1%), there are reports of serum transaminase (alt, AST), serum creatinine (AST), serum creatinine (ALT), serum creatinine (ALT), serum creatinine (AST), serum creatinine (ALT), serum creatinine (AST), serum creatinine (AST), serum creatinine (AST), serum creatinine (AST), serum γ- The levels of glutamyl transpeptidase, alkaline phosphatase and bilirubin increased temporarily. In rare cases (≥ 0.01% - < 0.1%), hepatocyte damage with cholestasis (hepatitis) has been observed.
Pancreas:
In rare cases (≥ 0.01% - < 0.1%), signs of pancreatitis were observed during or after roxithromycin treatment. Once treatment stops, these signs are reversible.
Heart:
In extremely rare (< 0.01%) cases, QT prolongation and arrhythmias such as ventricular tachycardia and torsade de pointe were reported (see [precautions] and [drug interactions]).
Nervous system:
In rare cases (≥ 0.01% - < 0.1%), headache, dizziness or paresthesia may occur. In rare cases (≥ 0.01% - < 0.1%), there were also reports of taste and / or olfactory disorders.
Other information:
The use of any antibiotic drugs will lead to the proliferation of pathogens that are not sensitive to the drugs used. Therefore, it is important to pay attention to any signs of secondary infection caused by these pathogens. Any secondary infection should be treated properly.
In rare cases (≥ 0.01% - < 0.1%), dual infection caused by Candida may occur, such as oral and vaginal mucosal infection.
Treatment of adverse reactions
Pseudomembranous enteritis
For such cases, doctors must consider stopping roxithromycin treatment according to the situation, and if necessary, appropriate treatment should be carried out immediately (such as the use of special antibiotics and chemotherapy that have been clinically confirmed to be effective). Drugs that inhibit peristalsis should not be taken.
Severe acute anaphylaxis (e.g. anaphylaxis)
In this case, roxithromycin should be stopped immediately, and routine first aid measures should be taken (such as antihistamines, corticosteroids, sympathomics, and ventilation if necessary).

Taboo:
Roxithromycin is forbidden to be used in patients who are allergic to active substance roxithromycin, other macrolide drugs, or any other ingredients in this product.
Drugs containing ergotamine or dihydroergotamine cannot be combined with ergotamine due to the risk of vasoconstriction enhancement (see drug interaction).

Matters needing attention:
Roxithromycin should be given to patients after careful evaluation of the risks and benefits of:
- congenital or acquired QT interval prolongation
- hypokalemia, hypomagnesemia
- clinically relevant bradycardia
- symptomatic heart failure
- History of arrhythmia
- taking drugs that can prolong QT interval at the same time (see drug interaction).
During the extended use of roxithromycin, liver function and renal function should be monitored.
Patients with impaired liver function should not take roxithromycin. However, if roxithromycin therapy is clearly required, laboratory parameters of liver function need to be monitored. For patients with severe liver damage, the dose should be halved (see usage and dosage).
If severe and persistent diarrhea occurs during treatment or within the first week after the start of treatment, pseudomembranous enteritis should be considered (see [adverse reactions]).
Impact on the ability to drive and operate the machine
Even when properly administered, the drug can still sufficiently affect the reaction (e.g. Vertigo - see [adverse reactions]), thereby impairing the patient's ability to drive, operate the machine, or work without firm support. These effects are more common at the beginning of treatment, after dose increase, and when shared with alcohol.

Medication for pregnant and lactating women:
Gestational period
No clinical experience of roxithromycin in pregnancy. Although the relevant tests conducted in various animals show no teratogenicity or fetal toxicity, roxithromycin should not be used during pregnancy unless it is considered that roxithromycin has clear indications after careful evaluation of risks and benefits.
lactation
There is no clinical experience of roxithromycin in lactation. The amount of roxithromycin secreted in breast milk is very small (less than 0.05% of the dose taken). However, suckling infants may have intestinal flora disorder, Candida albicans colonization and sensitization. Therefore, roxithromycin should not be used during lactation unless it is considered that roxithromycin has clear indications after careful evaluation of risks and benefits. In these cases, it is recommended to stop breastfeeding.

FAQ
1.who are we?
We are based in Fujian, China, start from 2000,sell to North America(40.00%),Southeast Asia(25.00%),Western Europe(25.00%),Africa(10.00%).There are total about 50 people in our office.

2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;

3.what can you buy from us?
Pharmaceutical production lines,Intermediates,APIs,Finished Drug Preparations & Vaccines.

4. why should you buy from us not from other suppliers?
We have our own manufacture factories and one professional sales team working for the clients all over the world.

5. what services can we provide?
Accepted Delivery Terms: FOB,CIF,EXW,DDP,Express Delivery;
Accepted Payment Currency:USD,EUR,CAD,AUD,GBP,CNY;
Accepted Payment Type: T/T,L/C,PayPal,Western Union;
Language Spoken:English,Chinese,Japanese

Our Ddvantage:
1. Quick delivery
2. Online payment
3. Quality assurance
4. Welcome big order
5. After-sales service 24 hours
6. Competitive advantage products
7. Our value information is "Quality is our culture"
8. Work with us to provide you with secure funds, your business is securely protected, our advantages

Our Service
a)  Free amples can be provided.
b) Guide customers through professional technology and teach them how to use our products after sale
c) Determine the lowest price of high-quality products
1. Skilled experience: Our company is a leading manufacturer of professional production in China pharmaceutical field for many years.
2. The highest quality: to ensure high quality, once any problems are found, the package will be re-shipped for you.
3. Safe transportation: by air express (FedEx, UPS, DHL, EMS). It is recommended that you choose the most professional freight forwarder.
4. Fast delivery: We have stock, so once payment is received, we can deliver quickly.
5. Quality service: We will provide you with enthusiastic after-sales service. If you have any questions, we will reply to youwithin 24 hours.
6. Competitive price: discounts will be obtained when making large orders.

Our Manufacture Factory
Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd is a comprehensive enterprise which integrates R & D, production and construction of pharmaceutical production equipments, development and transfer of biotechnology, and cooperative production and sales of drugs and vaccines. The self-developed pharmaceutical production equipment branded FUL has been put into operation in many well-known pharmaceutical enterprises  CSPC and also cooperates with many well-known pharmaceutical enterprises in production and sales, including pharmaceutical intermediates, APIs and finished drug preparations.

Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd business radiates to all levels, including direct supply cooperation with government departments and industry representatives, as well as establishing supply cooperation relationship with retail industry. We supply high quality, safe and effective medicines and medical equipment to governments, hospitals, clinics and licensed pharmacies in different countries with timely and effective services at reasonable prices.

At present Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd has the authorization to sell its intermediates and APIs,and has the authorizations of CSPC & HUABEI PHARM sell its finished drug preparations;then FUL is the only manufacture in China which can supply the complete service from pharmaceutical produciton lines,intermediates and APIs to finished drug preparations and vaccines.Then we are seeking the professional pharmaceutical enterprices to work together for further cooperations.




Factory View


Our Products


Our Business